7Baggers

Silo Pharma . Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20180930 20181231 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -1.66-0.510.641.792.944.095.246.39Milllion

Silo Pharma . Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 
  revenue18,026 18,025 18,025 18,026 18,026 18,025 18,025 18,026 18,026 18,025 68,085 47,433 22,128 16,285 2,216 294 40,301 268 -44 18 -239,806 152,404 376,222 -420,984 1,594 890,575 -67,128 -338,408 -286,451 22,507 79,273 -415,299 93,093 97,748 929 -184,253 -392,938 469,148 105,522 
  cost of revenue162,348 1,459 1,459 1,460 1,460 1,459 1,459 1,460 1,460 1,459 38,496 31,950 145,260 29,449 1,333 84 27,305 82 30,000 40,000 45,000 248,906 87,907 90,092 466,145 104,897 
  gross profit-144,322 16,566 16,566 16,566 16,566 16,566 16,566 16,566 16,566 16,566 29,589 15,483 -123,132 -13,164 883 210 12,996 186 27,528 -29,982 -279,806 107,404 376,222 -420,984 1,594 890,575 -67,128 -338,408 -286,451 22,507 -169,633 11,606 5,186 7,656 4,647 4,510 8,405 3,003 625 
  operating expenses                                       
  research and development336,965 174,495 130,719 202,913 634,684 375,795 105,676 170,279 475,948 70,514 112,496 67,989 35,111 17,364 1,306 35,019 63,465 
  sales, general and administrative                                       
  total operating expenses1,019,406 789,964 1,131,551 820,051 1,673,524 965,720 510,851 563,825 1,023,982 510,508 585,621 991,086 576,188 538,056 997,576 160,568 309,013 248,693 277,685 51,182 76,108 134,855 169,338 98,159 77,628 145,746 75,876 93,097 147,888 126,633 72,484 45,545 76,989 69,295 47,502 151,048 37,022 33,520 21,508 
  operating income-1,163,730 -773,398 -1,114,985 -803,485 -1,656,958 -949,154 -494,285 -547,259 -942,416 -463,942 -510,032 -968,103 -780,696 -636,220 -996,693 -159,358 -323,457 -242,507 -302,141 -81,164 -116,090 -134,847 -169,333 -91,655 -71,088 -138,312 -66,829 -81,841 -135,857 -109,131 -49,791 -33,939 -71,803 -61,639 -42,855 -146,538 -28,617 -30,517 -20,883 
  net income-1,121,176 -660,160 -1,012,951 -1,010,962 -1,663,994 -1,016,357 -822,142 -604,072 -1,088,686 6,385,119 -461,990 -930,702 -789,814 -633,795 -1,375,031 -238,877 -382,079 -265,481 -472,936 -198,162 -315,914 17,549 206,884 -519,143 -76,034 744,829 -143,004 -431,505 -434,339 -104,126 6,789 -460,844 16,104 28,453 -46,573 -335,301 -429,960 435,628 84,014 

We provide you with 20 years income statements for Silo Pharma . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Silo Pharma . stock. Explore the full financial landscape of Silo Pharma . stock with our expertly curated income statements.

The information provided in this report about Silo Pharma . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.